Dr. David T. Curiel, Professor of Radiation Oncology is a co-collaborator on the vector design for a novel inhaled or nasal vaccine that will soon be in Phase 1 clinical trials here in the US. 

This week our team successfully completed an adaptive treatment on a patient, once again utilizing our ViewRay Systems MRIdian machine. The MRIdian uses magnetic resonance imaging (MRI) to precisely target tumors in real time. This machine is also equipped with adaptive technology, allowing doctors to adjust treatment plans each day to account for changes in organ […]

Michael Waters, MD, PhD, has been awarded a WashU Gap Fund grant in the amount of $46,520. This fund is operated by the Office of Technology Management at WashU and the award is to support translational work for the technology, “Convolutional Neural Network Classification of Pretreatment Biopsies of Rectal Adenocarcinoma Predicts Complete Clinical Response to […]